Login / Signup

Low dose of emetine as potential anti-SARS-CoV-2 virus therapy: preclinical in vitro inhibition and in vivo pharmacokinetic evidences.

Aoli WangYong SunQingwang LiuHong WuJuan LiuJun HeJunling YuQing Qing ChenYinglu GeZhuhui ZhangChen HuCheng ChenZiping QiFengming ZouFeiyang LiuJie HuMing ZhaoTao HuangBeilei WangLi WangWei WangWenchao WangTao RenJing LiuYehuan SunSong FanQibing WuChaozhao LiangLiangdan SunBin SuWei WeiQing-Song Liu
Published in: Molecular Biomedicine (Online) (2020)
The online version contains supplementary material available at 10.1186/s43556-020-00018-9.
Keyphrases
  • sars cov
  • low dose
  • social media
  • respiratory syndrome coronavirus
  • high dose
  • cell therapy
  • psychometric properties
  • health information
  • human health
  • healthcare
  • climate change